In the solid tumors, there was a reduction in microvascularity and signs of increased hemorrhage, which might reflect collapse of tumor vasculature previously observed in the Omomyc tumor model after MYC inhibition (49) and after MYCMI-6 treatment in a MYCN-amplified neuroblastoma xenograft mouse model (8). The gene discussed is MYCN; the disease is neoplasm.